Clinical trials
Retinal Vein Occlusion trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 1 |
| 2015 | 7 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 53 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shahid Beheshti University of Medical Sciences | 3 |
| University of Toronto | 3 |
| Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 2 |
| He Eye Hospital | 2 |
| Rafic Hariri University Hospital | 2 |
| Renmin Hospital of Wuhan University | 2 |
| Targeted Therapy Technologies, LLC | 2 |
| Unity Health Toronto | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Assaf-Harofeh Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Vein Occlusion | 53 |
| Macular Edema | 14 |
| Macular Degeneration | 10 |
| Diabetic Retinopathy | 4 |
| Neovascularization, Pathologic | 3 |
| Choroidal Neovascularization | 2 |
| Epiretinal Membrane | 2 |
| Glaucoma | 2 |
| Retinal Artery Occlusion | 2 |
| Retinal Diseases | 2 |
Trials
Showing 51 to 53 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.